Sotomi Yohei, Iwakura Katsuomi, Higuchi Yoshiharu, Abe Kazuo, Yoshida Junko, Masai Takafumi, Fujii Kenshi
Cardiovascular Center, Sakurabashi-Watanabe Hospital, 2-4-32 Umeda, Kita-ku, Osaka, 530-0001, Japan,
J Clin Monit Comput. 2013 Dec;27(6):639-46. doi: 10.1007/s10877-013-9481-2. Epub 2013 Jun 8.
FloTrac/Vigileo™ system is based on arterial pressure waveform analysis arterial pressure-based CO (APCO). Therefore, systemic vascular resistance (SVR) can influence the accuracy of APCO. The purpose of this study is to evaluate the relationship between SVR and the accuracy of APCO. We managed 50 consecutive patients in the perioperative period of cardiac surgery with FloTrac/Vigileo™ system (v. 3.02) and Swan-Ganz catheter/Vigilance™ system pulmonary artery catheter-based CO (PAC-CO) simultaneously. Continuous hemodynamic measurement using both methods was performed every 20 s from the induction of anesthesia to PAC removal 4 h after extubation. A total of 11,092 (intraoperative), 38,455 (postoperative, pre-extubation), and 44,235 (postoperative, post-extubation) data pairs were finally analyzed. Bland-Altman analysis revealed that in the intraoperative [postoperative pre-extubation, post-extubation] period, the bias was 0.5 [0.1, 0.0] L/min and the limits of agreement ranged from -2.4 to 3.3 [-2.2 to 2.4, -2.4 to 2.3] L/min. The percentage error was 60.3 [54.5, 48.5] %. Regression analysis of the systemic vascular resistance index (SVRI) and the bias between APCO and PAC-CO showed that the bias was positively correlated to the SVRI. Subanalysis based on SVR with Lin's concordance correlation coefficient revealed that relatively satisfactory concordance was found in the normal-SVR group (concordance correlation coefficient ρ c = 0.51-0.56) regardless of vasoactive agent use. The accuracy of the FloTrac/Vigileo™ System (v. 3.02) is relatively satisfactory in the condition with normal SVR regardless of vasoactive agent use. Positive correlation between the bias and SVR can be the clue to the more effective use of FloTrac/Vigileo™ system.
FloTrac/Vigileo™系统基于动脉压波形分析,即基于动脉压的心输出量(APCO)。因此,体循环血管阻力(SVR)会影响APCO的准确性。本研究的目的是评估SVR与APCO准确性之间的关系。我们使用FloTrac/Vigileo™系统(版本3.02)和Swan-Ganz导管/Vigilance™系统肺动脉导管法心输出量(PAC-CO),对50例心脏手术围术期患者进行了连续管理。从麻醉诱导至拔管后4小时拔除肺动脉导管期间,每20秒使用这两种方法进行连续血流动力学测量。最终共分析了11,092对(术中)、38,455对(术后,拔管前)和44,235对(术后,拔管后)数据。Bland-Altman分析显示,在术中[术后拔管前、拔管后]期间,偏差为0.5[0.1, 0.0]L/min,一致性界限为-2.4至3.3[-2.2至2.4, -2.4至2.3]L/min。百分比误差为60.3[54.5, 48.5]%。体循环血管阻力指数(SVRI)与APCO和PAC-CO之间偏差的回归分析表明,偏差与SVRI呈正相关。基于SVR并使用Lin一致性相关系数的亚组分析显示,无论是否使用血管活性药物,在正常SVR组中均发现了相对满意的一致性(一致性相关系数ρc = 0.51 - 0.56)。无论是否使用血管活性药物,在SVR正常的情况下,FloTrac/Vigileo™系统(版本3.02)的准确性相对令人满意。偏差与SVR之间的正相关关系可能是更有效使用FloTrac/Vigileo™系统的线索。